Global Parkinson Treatment Drug Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Parkinson Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson Treatment Drug.
The Parkinson Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Parkinson Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Parkinson Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Parkinson Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Bausch Health
- Sinemet-CR
- Piribedil
- Madopar
- COMT Inhibitor
- Others
- Male Patient
- Female Patient
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sinemet-CR
1.2.3 Piribedil
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Parkinson Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Male Patient
1.3.3 Female Patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Parkinson Treatment Drug Market Perspective (2018-2029)
2.2 Parkinson Treatment Drug Growth Trends by Region
2.2.1 Global Parkinson Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Parkinson Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Parkinson Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Parkinson Treatment Drug Market Dynamics
2.3.1 Parkinson Treatment Drug Industry Trends
2.3.2 Parkinson Treatment Drug Market Drivers
2.3.3 Parkinson Treatment Drug Market Challenges
2.3.4 Parkinson Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Parkinson Treatment Drug Players by Revenue
3.1.1 Global Top Parkinson Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Parkinson Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson Treatment Drug Revenue
3.4 Global Parkinson Treatment Drug Market Concentration Ratio
3.4.1 Global Parkinson Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Treatment Drug Revenue in 2022
3.5 Parkinson Treatment Drug Key Players Head office and Area Served
3.6 Key Players Parkinson Treatment Drug Product Solution and Service
3.7 Date of Enter into Parkinson Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARKINSON TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Parkinson Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Parkinson Treatment Drug Forecasted Market Size by Type (2024-2029)
5 PARKINSON TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Parkinson Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Parkinson Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Parkinson Treatment Drug Market Size (2018-2029)
6.2 North America Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Parkinson Treatment Drug Market Size by Country (2018-2023)
6.4 North America Parkinson Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Parkinson Treatment Drug Market Size (2018-2029)
7.2 Europe Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Parkinson Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Parkinson Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Parkinson Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Parkinson Treatment Drug Market Size (2018-2029)
9.2 Latin America Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Parkinson Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Parkinson Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Treatment Drug Introduction
11.1.4 Merck Revenue in Parkinson Treatment Drug Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Detail
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Treatment Drug Introduction
11.2.4 Akorn Revenue in Parkinson Treatment Drug Business (2018-2023)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Treatment Drug Introduction
11.3.4 GSK Revenue in Parkinson Treatment Drug Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Treatment Drug Introduction
11.4.4 Novartis Revenue in Parkinson Treatment Drug Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Treatment Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Detail
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Treatment Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2018-2023)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Treatment Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Treatment Drug Business (2018-2023)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Detail
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2018-2023)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Treatment Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Treatment Drug Business (2018-2023)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Detail
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Treatment Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Detail
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2018-2023)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Detail
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2018-2023)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Detail
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Treatment Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Treatment Drug Business (2018-2023)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Detail
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Treatment Drug Introduction
11.14.4 Valeant Revenue in Parkinson Treatment Drug Business (2018-2023)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Detail
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Treatment Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Treatment Drug Business (2018-2023)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Detail
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Treatment Drug Introduction
11.16.4 Orion Revenue in Parkinson Treatment Drug Business (2018-2023)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Detail
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Treatment Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Detail
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Treatment Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Treatment Drug Business (2018-2023)
11.18.5 US WorldMeds Recent Development
11.19 Bausch Health
11.19.1 Bausch Health Company Detail
11.19.2 Bausch Health Business Overview
11.19.3 Bausch Health Parkinson Treatment Drug Introduction
11.19.4 Bausch Health Revenue in Parkinson Treatment Drug Business (2018-2023)
11.19.5 Bausch Health Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sinemet-CR
1.2.3 Piribedil
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Others
1.3 Market by Application
1.3.1 Global Parkinson Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Male Patient
1.3.3 Female Patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Parkinson Treatment Drug Market Perspective (2018-2029)
2.2 Parkinson Treatment Drug Growth Trends by Region
2.2.1 Global Parkinson Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Parkinson Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Parkinson Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Parkinson Treatment Drug Market Dynamics
2.3.1 Parkinson Treatment Drug Industry Trends
2.3.2 Parkinson Treatment Drug Market Drivers
2.3.3 Parkinson Treatment Drug Market Challenges
2.3.4 Parkinson Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Parkinson Treatment Drug Players by Revenue
3.1.1 Global Top Parkinson Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Parkinson Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson Treatment Drug Revenue
3.4 Global Parkinson Treatment Drug Market Concentration Ratio
3.4.1 Global Parkinson Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson Treatment Drug Revenue in 2022
3.5 Parkinson Treatment Drug Key Players Head office and Area Served
3.6 Key Players Parkinson Treatment Drug Product Solution and Service
3.7 Date of Enter into Parkinson Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARKINSON TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Parkinson Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Parkinson Treatment Drug Forecasted Market Size by Type (2024-2029)
5 PARKINSON TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Parkinson Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Parkinson Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Parkinson Treatment Drug Market Size (2018-2029)
6.2 North America Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Parkinson Treatment Drug Market Size by Country (2018-2023)
6.4 North America Parkinson Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Parkinson Treatment Drug Market Size (2018-2029)
7.2 Europe Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Parkinson Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Parkinson Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Parkinson Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Parkinson Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Parkinson Treatment Drug Market Size (2018-2029)
9.2 Latin America Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Parkinson Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Parkinson Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Parkinson Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Parkinson Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson Treatment Drug Introduction
11.1.4 Merck Revenue in Parkinson Treatment Drug Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Detail
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson Treatment Drug Introduction
11.2.4 Akorn Revenue in Parkinson Treatment Drug Business (2018-2023)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson Treatment Drug Introduction
11.3.4 GSK Revenue in Parkinson Treatment Drug Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson Treatment Drug Introduction
11.4.4 Novartis Revenue in Parkinson Treatment Drug Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson Treatment Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Detail
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson Treatment Drug Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2018-2023)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson Treatment Drug Introduction
11.7.4 Abbvie Revenue in Parkinson Treatment Drug Business (2018-2023)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Detail
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2018-2023)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson Treatment Drug Introduction
11.9.4 Astellas Pharma Revenue in Parkinson Treatment Drug Business (2018-2023)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Detail
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson Treatment Drug Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Detail
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Parkinson Treatment Drug Introduction
11.11.4 Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2018-2023)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Detail
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Parkinson Treatment Drug Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2018-2023)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
11.13.1 H.Lundbeck Company Detail
11.13.2 H.Lundbeck Business Overview
11.13.3 H.Lundbeck Parkinson Treatment Drug Introduction
11.13.4 H.Lundbeck Revenue in Parkinson Treatment Drug Business (2018-2023)
11.13.5 H.Lundbeck Recent Development
11.14 Valeant
11.14.1 Valeant Company Detail
11.14.2 Valeant Business Overview
11.14.3 Valeant Parkinson Treatment Drug Introduction
11.14.4 Valeant Revenue in Parkinson Treatment Drug Business (2018-2023)
11.14.5 Valeant Recent Development
11.15 Apokyn
11.15.1 Apokyn Company Detail
11.15.2 Apokyn Business Overview
11.15.3 Apokyn Parkinson Treatment Drug Introduction
11.15.4 Apokyn Revenue in Parkinson Treatment Drug Business (2018-2023)
11.15.5 Apokyn Recent Development
11.16 Orion
11.16.1 Orion Company Detail
11.16.2 Orion Business Overview
11.16.3 Orion Parkinson Treatment Drug Introduction
11.16.4 Orion Revenue in Parkinson Treatment Drug Business (2018-2023)
11.16.5 Orion Recent Development
11.17 Stada Arzneimittel
11.17.1 Stada Arzneimittel Company Detail
11.17.2 Stada Arzneimittel Business Overview
11.17.3 Stada Arzneimittel Parkinson Treatment Drug Introduction
11.17.4 Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023)
11.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
11.18.1 US WorldMeds Company Detail
11.18.2 US WorldMeds Business Overview
11.18.3 US WorldMeds Parkinson Treatment Drug Introduction
11.18.4 US WorldMeds Revenue in Parkinson Treatment Drug Business (2018-2023)
11.18.5 US WorldMeds Recent Development
11.19 Bausch Health
11.19.1 Bausch Health Company Detail
11.19.2 Bausch Health Business Overview
11.19.3 Bausch Health Parkinson Treatment Drug Introduction
11.19.4 Bausch Health Revenue in Parkinson Treatment Drug Business (2018-2023)
11.19.5 Bausch Health Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Parkinson Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Piribedil
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Others
Table 7. Global Parkinson Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Parkinson Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Parkinson Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Parkinson Treatment Drug Market Share by Region (2018-2023)
Table 11. Global Parkinson Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Parkinson Treatment Drug Market Share by Region (2024-2029)
Table 13. Parkinson Treatment Drug Market Trends
Table 14. Parkinson Treatment Drug Market Drivers
Table 15. Parkinson Treatment Drug Market Challenges
Table 16. Parkinson Treatment Drug Market Restraints
Table 17. Global Parkinson Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Parkinson Treatment Drug Market Share by Players (2018-2023)
Table 19. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2022)
Table 20. Ranking of Global Top Parkinson Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Parkinson Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson Treatment Drug Product Solution and Service
Table 24. Date of Enter into Parkinson Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Parkinson Treatment Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Parkinson Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Parkinson Treatment Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Parkinson Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Parkinson Treatment Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Parkinson Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Parkinson Treatment Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Parkinson Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Parkinson Treatment Drug Product
Table 52. Merck Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Detail
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson Treatment Drug Product
Table 57. Akorn Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Parkinson Treatment Drug Product
Table 62. GSK Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson Treatment Drug Product
Table 67. Novartis Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Detail
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson Treatment Drug Product
Table 72. Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Detail
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson Treatment Drug Product
Table 77. Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Detail
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson Treatment Drug Product
Table 82. Abbvie Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Detail
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Detail
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson Treatment Drug Product
Table 92. Astellas Pharma Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Desitin Arzneimittel Company Detail
Table 95. Desitin Arzneimittel Business Overview
Table 96. Desitin Arzneimittel Parkinson Treatment Drug Product
Table 97. Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 98. Desitin Arzneimittel Recent Development
Table 99. Endo Pharmaceuticals Company Detail
Table 100. Endo Pharmaceuticals Business Overview
Table 101. Endo Pharmaceuticals Parkinson Treatment Drug Product
Table 102. Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 103. Endo Pharmaceuticals Recent Development
Table 104. F.Hoffmann-La Roche Company Detail
Table 105. F.Hoffmann-La Roche Business Overview
Table 106. F.Hoffmann-La Roche Parkinson Treatment Drug Product
Table 107. F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 108. F.Hoffmann-La Roche Recent Development
Table 109. H.Lundbeck Company Detail
Table 110. H.Lundbeck Business Overview
Table 111. H.Lundbeck Parkinson Treatment Drug Product
Table 112. H.Lundbeck Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 113. H.Lundbeck Recent Development
Table 114. Valeant Company Detail
Table 115. Valeant Business Overview
Table 116. Valeant Parkinson Treatment Drug Product
Table 117. Valeant Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 118. Valeant Recent Development
Table 119. Apokyn Company Detail
Table 120. Apokyn Business Overview
Table 121. Apokyn Parkinson Treatment Drug Product
Table 122. Apokyn Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 123. Apokyn Recent Development
Table 124. Orion Company Detail
Table 125. Orion Business Overview
Table 126. Orion Parkinson Treatment Drug Product
Table 127. Orion Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 128. Orion Recent Development
Table 129. Stada Arzneimittel Company Detail
Table 130. Stada Arzneimittel Business Overview
Table 131. Stada Arzneimittel Parkinson Treatment Drug Product
Table 132. Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 133. Stada Arzneimittel Recent Development
Table 134. US WorldMeds Company Detail
Table 135. US WorldMeds Business Overview
Table 136. US WorldMeds Parkinson Treatment Drug Product
Table 137. US WorldMeds Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 138. US WorldMeds Recent Development
Table 139. Bausch Health Company Detail
Table 140. Bausch Health Business Overview
Table 141. Bausch Health Parkinson Treatment Drug Product
Table 142. Bausch Health Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 143. Bausch Health Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Global Parkinson Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Piribedil
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Others
Table 7. Global Parkinson Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Parkinson Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Parkinson Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Parkinson Treatment Drug Market Share by Region (2018-2023)
Table 11. Global Parkinson Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Parkinson Treatment Drug Market Share by Region (2024-2029)
Table 13. Parkinson Treatment Drug Market Trends
Table 14. Parkinson Treatment Drug Market Drivers
Table 15. Parkinson Treatment Drug Market Challenges
Table 16. Parkinson Treatment Drug Market Restraints
Table 17. Global Parkinson Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Parkinson Treatment Drug Market Share by Players (2018-2023)
Table 19. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2022)
Table 20. Ranking of Global Top Parkinson Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Parkinson Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson Treatment Drug Product Solution and Service
Table 24. Date of Enter into Parkinson Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Parkinson Treatment Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Parkinson Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Parkinson Treatment Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Parkinson Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Parkinson Treatment Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Parkinson Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Parkinson Treatment Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Parkinson Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Parkinson Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Parkinson Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Parkinson Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Merck Company Detail
Table 50. Merck Business Overview
Table 51. Merck Parkinson Treatment Drug Product
Table 52. Merck Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Detail
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson Treatment Drug Product
Table 57. Akorn Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Detail
Table 60. GSK Business Overview
Table 61. GSK Parkinson Treatment Drug Product
Table 62. GSK Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Detail
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson Treatment Drug Product
Table 67. Novartis Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Detail
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson Treatment Drug Product
Table 72. Boehringer Ingelheim Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Detail
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson Treatment Drug Product
Table 77. Teva Pharmaceutical Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Detail
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson Treatment Drug Product
Table 82. Abbvie Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Detail
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson Treatment Drug Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Detail
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson Treatment Drug Product
Table 92. Astellas Pharma Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Desitin Arzneimittel Company Detail
Table 95. Desitin Arzneimittel Business Overview
Table 96. Desitin Arzneimittel Parkinson Treatment Drug Product
Table 97. Desitin Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 98. Desitin Arzneimittel Recent Development
Table 99. Endo Pharmaceuticals Company Detail
Table 100. Endo Pharmaceuticals Business Overview
Table 101. Endo Pharmaceuticals Parkinson Treatment Drug Product
Table 102. Endo Pharmaceuticals Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 103. Endo Pharmaceuticals Recent Development
Table 104. F.Hoffmann-La Roche Company Detail
Table 105. F.Hoffmann-La Roche Business Overview
Table 106. F.Hoffmann-La Roche Parkinson Treatment Drug Product
Table 107. F.Hoffmann-La Roche Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 108. F.Hoffmann-La Roche Recent Development
Table 109. H.Lundbeck Company Detail
Table 110. H.Lundbeck Business Overview
Table 111. H.Lundbeck Parkinson Treatment Drug Product
Table 112. H.Lundbeck Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 113. H.Lundbeck Recent Development
Table 114. Valeant Company Detail
Table 115. Valeant Business Overview
Table 116. Valeant Parkinson Treatment Drug Product
Table 117. Valeant Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 118. Valeant Recent Development
Table 119. Apokyn Company Detail
Table 120. Apokyn Business Overview
Table 121. Apokyn Parkinson Treatment Drug Product
Table 122. Apokyn Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 123. Apokyn Recent Development
Table 124. Orion Company Detail
Table 125. Orion Business Overview
Table 126. Orion Parkinson Treatment Drug Product
Table 127. Orion Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 128. Orion Recent Development
Table 129. Stada Arzneimittel Company Detail
Table 130. Stada Arzneimittel Business Overview
Table 131. Stada Arzneimittel Parkinson Treatment Drug Product
Table 132. Stada Arzneimittel Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 133. Stada Arzneimittel Recent Development
Table 134. US WorldMeds Company Detail
Table 135. US WorldMeds Business Overview
Table 136. US WorldMeds Parkinson Treatment Drug Product
Table 137. US WorldMeds Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 138. US WorldMeds Recent Development
Table 139. Bausch Health Company Detail
Table 140. Bausch Health Business Overview
Table 141. Bausch Health Parkinson Treatment Drug Product
Table 142. Bausch Health Revenue in Parkinson Treatment Drug Business (2018-2023) & (US$ Million)
Table 143. Bausch Health Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Parkinson Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Parkinson Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Sinemet-CR Features
Figure 4. Piribedil Features
Figure 5. Madopar Features
Figure 6. COMT Inhibitor Features
Figure 7. Others Features
Figure 8. Global Parkinson Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Parkinson Treatment Drug Market Share by Application: 2022 VS 2029
Figure 10. Male Patient Case Studies
Figure 11. Female Patient Case Studies
Figure 12. Parkinson Treatment Drug Report Years Considered
Figure 13. Global Parkinson Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Parkinson Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Parkinson Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Parkinson Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Parkinson Treatment Drug Revenue in 2022
Figure 19. North America Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Parkinson Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Merck Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 48. Akorn Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 49. GSK Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 52. Teva Pharmaceutical Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 53. Abbvie Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 54. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 55. Astellas Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 56. Desitin Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 57. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 58. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 59. H.Lundbeck Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 60. Valeant Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 61. Apokyn Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 62. Orion Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 63. Stada Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 64. US WorldMeds Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 65. Bausch Health Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Parkinson Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Parkinson Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Sinemet-CR Features
Figure 4. Piribedil Features
Figure 5. Madopar Features
Figure 6. COMT Inhibitor Features
Figure 7. Others Features
Figure 8. Global Parkinson Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Parkinson Treatment Drug Market Share by Application: 2022 VS 2029
Figure 10. Male Patient Case Studies
Figure 11. Female Patient Case Studies
Figure 12. Parkinson Treatment Drug Report Years Considered
Figure 13. Global Parkinson Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Parkinson Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Parkinson Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Parkinson Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Parkinson Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Parkinson Treatment Drug Revenue in 2022
Figure 19. North America Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Parkinson Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Parkinson Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Parkinson Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Merck Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 48. Akorn Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 49. GSK Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 52. Teva Pharmaceutical Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 53. Abbvie Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 54. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 55. Astellas Pharma Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 56. Desitin Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 57. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 58. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 59. H.Lundbeck Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 60. Valeant Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 61. Apokyn Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 62. Orion Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 63. Stada Arzneimittel Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 64. US WorldMeds Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 65. Bausch Health Revenue Growth Rate in Parkinson Treatment Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
